Capeding, Maria Rosario Z <br/><br/>
Safety and immunogenicity of the killed bivalent (O1 and O139) whole-cell cholera vaccine in the Philippines.  [electronic resource] 

 -  Human vaccines & immunotherapeutics  10 2017 
 - 2232-2239 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase IV; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2164-554X 
<br/><br/><label>Standard No.: </label>10.1080/21645515.2017.1342908  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Adolescent<br/>Antibodies, Bacterial--blood<br/>Child<br/>Child, Preschool<br/>Cholera--epidemiology<br/>Cholera Vaccines--administration & dosage<br/>Female<br/>Humans<br/>Immunogenicity, Vaccine<br/>Infant<br/>Male<br/>Philippines--epidemiology<br/>Seroconversion<br/>Vaccination<br/>Vaccines, Inactivated--administration & dosage<br/>Vibrio cholerae O1--immunology